Search Results - "Kawasaki, Rika"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Drug-induced liver injury after allogeneic bone marrow transplantation by Tachibana, Takayoshi, Nozaki, Akito, Enaka, Makiko, Yamamoto, Eri, Kawasaki, Rika, Koharazawa, Hideyuki, Hagihara, Maki, Ishibashi, Daisuke, Nakajima, Yuki, Kuwabara, Hideyuki, Tomita, Naoto, Ishigatsubo, Yoshiaki, Fujisawa, Shin

    Published in International journal of hematology (01-10-2013)
    “…A 23-year-old woman developed acute severe hepatitis and jaundice on day 183 after bone marrow transplantation from HLA-B antigen mismatched-related donor. The…”
    Get full text
    Journal Article
  6. 6

    Effect of bovine lactoferrin feeding on lipopolysaccharide-induced metabolic and hormonal disturbances in preruminant calves by Kushibiki, S.(National Inst. of Livestock and Grassland Science, Tsukuba, Ibaraki (Japan)), Shingu, H, Kawasaki, R, Komatsu, T, Itoh, F, Watanabe, A, Touno, E, Oshibe, A, Katoh, K, Obara, Y, Hodate, K

    Published in Animal science journal (01-06-2008)
    “…One of the biological functions of bovine lactoferrin (LF) is modulation of the host defense system, including cytokine production and immune response. The aim…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Totally Implantable Central Venous Access Port-Associated Bloodstream Infection Caused by Corynebacterium provencense: The First Case Report by Nishigaki, Tetsuta, Tanaka, Katsushi, Kawasaki, Rika, Hashiguchi, Shunta, Kato, Hideaki

    Published in Curēus (Palo Alto, CA) (11-10-2024)
    “…Corynebacterium species are associated with healthcare-associated infections, specifically in device implantation. Here, we report a rare case of a 44-year-old…”
    Get full text
    Journal Article
  9. 9

    Efficacy and safety of a 5-day regimen of azacitidine for patients with high-risk myelodysplastic syndromes by Fujimaki, Katsumichi, Miyashita, Kazuho, Kawasaki, Rika, Tomita, Naoto

    Published in European journal of haematology (01-09-2016)
    “…Although a 7‐day (d) regimen of azacitidine (AZA) is the standard treatment of high‐risk myelodysplastic syndromes (MDS), AZA is difficult to administer during…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Effect of Ondansetron on Postoperative Nausea and Vomiting and Food Intake after Knee Arthroplasty by MURAKAMI, Tomoko, KAWASAKI, Rika, FUKUCHI, Kaho, CHO, Sungsam, SHIROZU, Kazuhiro, YAMAURA, Ken

    Published in Nihon Rinshō Masui Gakkai shi (15-07-2023)
    “…Patients who underwent knee arthroplasty under general anesthesia were evaluated for the incidence of postoperative nausea and vomiting(PONV)and food intake in…”
    Get full text
    Journal Article
  12. 12

    Efficacy and Safety of a 5-Day Regimen of Azacitidine for Patients with High-Risk Myelodysplastic Syndromes by Fujimaki, Katsumichi, Miyashita, Kazuho, Kawasaki, Rika, Tomita, Naoto, Ishigatsubo, Yoshiaki

    Published in Blood (06-12-2014)
    “…Background: In the AZA-001 trial, azacitidine (AZA; 75 mg/m2per day for 7 consecutive days of every 28-day cycle) demonstrated improved survival compared with…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Prognostic Impact Of Gender In Diffuse Large B Cell Lymphoma Patients Treated With R-CHOP Therapy by Takahashi, Hiroyuki, Tomita, Naoto, Kawasaki, Rika, Hashimoto, Chizuko, Yamazaki, Etsuko, Taguchi, Jun, Sakai, Rika, Fujisawa, Shin, Ogawa, Koji, Ishigatsubo, Yoshiaki

    Published in Blood (15-11-2013)
    “…Since the introduction of rituximab, an anti-CD20 monoclonal antibody, the prognosis of patients with CD20-positive non-Hodgkin lymphoma has significantly…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20